Why are many patients with #epilepsy still receiving narrow testing, like multi-gene panels? Oftentimes, it’s about opening doors. GeneDx’s Epilepsy Partnership Program helps eligible pediatric patients access guideline-backed #exome sequencing, even if they’re uninsured or their insurance provider denies coverage. Your patients deserve answers—and not to worry about access to exome sequencing. Learn more at https://genedx.co/467Sbih
GeneDx’s Post
More Relevant Posts
-
New phase 3 data on #linaclotide for functional #constipation in pediatric patients aged 6 to 17 years. Linaclotide-treated patients achieved a greater than 2-fold least squares mean change from baseline in SBMs/week (2.220) vs placebo (1.050) (P < 0.0001). MORE: https://lnkd.in/ep5NY9HS
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
-
Silent rejection also known as subclinical acute rejection, or subAR is the earliest form of rejection and extremely common in kidney transplant patients. Learn how to stay ahead of silent rejection by visiting https://lnkd.in/grfMJKR3 #TransplantGenomics #TruGraf #TransplantNews #SilentKidneyTransplantRejection #GiftOfLife #DonateLife
-
More from this author
-
GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel
-
PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic
-
GeneDx to Participate in World Orphan Drug Congress Keynote and Panel Presentations